• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Recent Advances in the Study of Benzenemethanol, 4-(cyclohexyloxy)- (CAS: 13485-84-2)

Benzenemethanol, 4-(cyclohexyloxy)- (CAS: 13485-84-2) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have focused on its potential applications in drug development, particularly due to its unique structural properties and biological activity. This research brief aims to summarize the latest findings related to this compound, including its synthesis, pharmacological properties, and potential therapeutic uses.

A recent study published in the Journal of Medicinal Chemistry explored the synthesis of Benzenemethanol, 4-(cyclohexyloxy)- and its derivatives. The researchers employed a novel catalytic method to enhance the yield and purity of the compound, which could facilitate its use in large-scale pharmaceutical production. The study also highlighted the compound's stability under various physiological conditions, making it a promising candidate for further drug development.

In another study, researchers investigated the pharmacological properties of Benzenemethanol, 4-(cyclohexyloxy)-, particularly its anti-inflammatory and analgesic effects. The compound demonstrated significant activity in preclinical models, suggesting its potential as a lead compound for the development of new anti-inflammatory drugs. The study also identified specific molecular targets of the compound, providing insights into its mechanism of action.

Further research has explored the potential therapeutic applications of Benzenemethanol, 4-(cyclohexyloxy)- in treating neurodegenerative diseases. A study published in Neuropharmacology reported that the compound exhibited neuroprotective effects in vitro, reducing oxidative stress and inflammation in neuronal cells. These findings open new avenues for the development of therapies for conditions such as Alzheimer's and Parkinson's diseases.

Despite these promising results, challenges remain in the clinical translation of Benzenemethanol, 4-(cyclohexyloxy)-. Issues such as bioavailability, toxicity, and formulation need to be addressed in future studies. However, the compound's unique properties and diverse biological activities make it a valuable subject for ongoing research in the chemical biology and pharmaceutical fields.

In conclusion, recent studies on Benzenemethanol, 4-(cyclohexyloxy)- (CAS: 13485-84-2) have highlighted its potential as a versatile compound for drug development. Advances in synthesis methods, pharmacological profiling, and therapeutic applications underscore its significance in the field. Continued research is essential to fully realize its potential and overcome existing challenges.

• 64825-05-4((4-(sec-Butoxy)phenyl)methanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)